Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
5.14B
Enterprise Value
5.00B
Income
-
Sales
-
Book/sh
12.87
Cash/sh
0.74
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
8000
IPO
Mar 06, 2026
P/E
-
Forward P/E
25.62
PEG
-
P/S
-
P/B
1.42
P/C
24.85
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
1.36
Current Ratio
1.81
Debt/Eq
0.02
LT Debt/Eq
0.01
Option/Short
Yes / Yes
EPS (ttm)
-
EPS next Y
0.71
EPS next Q
-
EPS this Y
154.22%
EPS next Y
2.00%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
100.00%
Sales Q/Q
16.44%
Insider Own
0.55%
Insider Trans
0.00%
Inst Own
20.76%
Inst Trans
1.98%
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-1.71%
SMA50
-9.30%
SMA200
10.14%
Trades
Shs Outstand
281.21M
Shs Float
279.80M
52W High
24.43 -25.17%
52W Low
10.65 71.64%
Volatility
4.48% 4.89%
ATR (14)
0.88
RSI (14)
43.82
Beta
-
Rel Volume
0.00
Avg Volume
7.11M
Volume
0
Perf Week
-0.33%
Perf Month
-6.73%
Perf Quarter
-4.29%
Perf Half Y
50.95%
Perf YTD
-4.04%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
18.28
Price
18.28
Change %
0.00%
Consensus
Buy
Avg. Price Target
$25.87
Implied Upside
+41.5%
Analysts17incl. previous ratings
Rating Distribution14 Buy · 3 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 13, 2026Initiated
RRothschild & Co Redburn
Buy$30+64.1%
Oct 12, 2026Initiated
JEF logoJJefferies
Hold$22+20.4%
Oct 07, 2026Initiated
BCS logoBBarclays
Equal Weight$22+20.4%
Sep 24, 2026Initiated
TFC logoTTruist
Buy$29+58.6%
Jul 28, 2026Initiated
UBS logoUUBS
Buy$25+36.8%
May 12, 2026Initiated
TThe Benchmark Company
Buy$20+9.4%
Mar 31, 2026Initiated
WWilliam Blair
Outperform
Mar 31, 2026Initiated
WFC logoWWells Fargo
Overweight$26+42.2%
Mar 31, 2026Initiated
PPiper Sandler
Neutral$16-12.5%
Mar 31, 2026Initiated
MS logoMMorgan Stanley
Overweight$19+3.9%
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
CEO & DirectorMs. Que Thanh Dallara
Executive VP & CFOMr. Chad J. Spooner
Executive VP and Chief Product & Technology OfficerMr. Ali Dianaty
Senior VP & Chief Human Resources OfficerMs. Gillian Chandrasena
PresidentMr. Christopher E. Eso